收费全文 | 57884篇 |
免费 | 4883篇 |
国内免费 | 4968篇 |
2024年 | 120篇 |
2023年 | 649篇 |
2022年 | 1486篇 |
2021年 | 2896篇 |
2020年 | 1961篇 |
2019年 | 2453篇 |
2018年 | 2512篇 |
2017年 | 1802篇 |
2016年 | 2449篇 |
2015年 | 3585篇 |
2014年 | 4230篇 |
2013年 | 4619篇 |
2012年 | 5412篇 |
2011年 | 4774篇 |
2010年 | 3144篇 |
2009年 | 2497篇 |
2008年 | 3097篇 |
2007年 | 2713篇 |
2006年 | 2435篇 |
2005年 | 2071篇 |
2004年 | 1794篇 |
2003年 | 1635篇 |
2002年 | 1446篇 |
2001年 | 1056篇 |
2000年 | 907篇 |
1999年 | 959篇 |
1998年 | 554篇 |
1997年 | 515篇 |
1996年 | 468篇 |
1995年 | 427篇 |
1994年 | 441篇 |
1993年 | 330篇 |
1992年 | 394篇 |
1991年 | 317篇 |
1990年 | 274篇 |
1989年 | 242篇 |
1988年 | 174篇 |
1987年 | 133篇 |
1986年 | 132篇 |
1985年 | 118篇 |
1984年 | 93篇 |
1983年 | 72篇 |
1982年 | 58篇 |
1981年 | 28篇 |
1980年 | 19篇 |
1979年 | 24篇 |
1976年 | 13篇 |
1975年 | 13篇 |
1973年 | 21篇 |
1958年 | 13篇 |
We aimed to illustrate the roles and molecular mechanisms of ID2-AS1 in parkinson’s disease (PD). Methods: qRT-PCR detected the expression of ID2-AS1. CCK-8, LDH release assays the effect of ID2-AS1 knockdown on PD cells. Flow cytometry and Western Blot were used to detect the effect of ID2-AS1 inhibition on PD cell apoptosis. ELISA analysis showed that ID2-AS1 inhibition can reduce the inflammation of PD cells. ROS activity assay showed that inhibiting ID2-AS1 attenuated the oxidative stress induced by 1-methy1-4-phenylpyridinium (MPP+). RNA binding protein immunoprecipitation assay showed that ID2-AS1 is mainly located in the cytoplasm. The luciferase reporter assay is used to verify the interaction. In our study, ID2-AS1 was concentration-dependently and time-dependently up-regulated in MPP+?-treated human neuroblastoma cell line SH-SY5Y. ID2-AS1 knockdown enhanced cell proliferation and decreased cell death in PD cells. Knockdown of ID2-AS1 attenuates MPP+?-induced cytotoxicity in SH-SY5Y cells. ID2-AS1 is a sponge of miR-199a-5p. IFNAR1 is a target of miR-199a-5p. Inhibition of miR-199a-5p and overexpression of IFNAR1 alleviate the inhibitory effect of ID2-AS1 knockdown on MPP+?triggered neuronal injury. Inhibition of miR-199a-5p and overexpression of IFNAR1 alleviate the inhibitory effect of ID2-AS1 knockdown on MPP+?-triggered JAK2/STAT1 activation. Overall, down-regulation of ID2-AS1 alleviated the neuronal injury in PD through regulating miR-199a-5p/IFNAR1/JAK2/STAT1 axis.
相似文献Cerebral ischaemia/reperfusion (I/R) injury-induced irreversible brain injury is a major cause of mortality and functional impairment in ageing people. Gastrodin (GAS), derived from the traditional Chinese herbal medicine Tianma, has been reported to inhibit the progression of stroke, but the mechanism whereby GAS modulates the progression of cerebral I/R remains unclear. The middle cerebral artery occlusion method was used as a model of I/R in vivo. Rats were pretreated with GAS by intraperitoneal injection 7 days before I/R surgery and were then treated with GAS for 7 days after I/R surgery. Additionally, an oxygen–glucose deprivation/reoxygenation model using neuronal cells was established in vitro to simulate I/R injury. 2,3,5-Triphenyltetrazolium chloride and Nissl staining were used to evaluate infarct size and neuronal damage, respectively. Lactate dehydrogenase release and cell counting kit-8 assays were used to assess neuronal cell viability. Enzyme-linked immunosorbent assay, qPCR, flow cytometry and western blotting were performed to analyse the expression levels of inflammatory factors (IL-1β, IL-18), lncRNA NEAT1, miR-22-3p, NLRP3 and cleaved caspase-1. Luciferase reporter experiments were performed to verify the association between lncRNA NEAT1 and miR-22-3p. The results indicated that GAS could significantly improve the neurological scores of rats and reduce the area of cerebral infarction. Meanwhile, GAS inhibited pyroptosis by downregulating NLRP3, inflammatory factors (IL-1β, IL-18) and cleaved caspase-1. In addition, GAS attenuated I/R-induced inflammation in neuronal cells through the modulation of the lncRNA NEAT1/miR-22-3p axis. GAS significantly attenuated cerebral I/R injury via modulation of the lncRNA NEAT1/miR-22-3p axis. Thus, GAS might serve as a new agent for the treatment of cerebral I/R injury.
相似文献